Fundraising Fox

Luminoma

Auckland, NZ · 3 known investors

Luminoma is developing the LumAssure, a portable diagnostic-aid that uses Raman spectroscopy to non-invasively assess whether a skin lesion is likely malignant or benign within seconds. The device is intended to help clinicians make more objective skin cancer biopsy decisions and reduce unnecessary biopsies.

AI & Machine LearningDeep TechHealthtechMedical Devices

Founders & leadership

CSCather Simpson
Cather SimpsonCo-founder & Founder Director
MNMichel Nieuwoudt
Michel NieuwoudtChief Scientific Officer

Investors · 3

Angel HQWellington · $5K – $600K
Bridgewest VenturesAuckland
Pacific ChannelAuckland

Frequently asked questions

What does Luminoma do?
Luminoma is developing the LumAssure, a portable diagnostic-aid that uses Raman spectroscopy to non-invasively assess whether a skin lesion is likely malignant or benign within seconds. The device is intended to help clinicians make more objective skin cancer biopsy decisions and reduce unnecessary biopsies.
Who founded Luminoma?
Luminoma was founded by Cather Simpson.
Who are Luminoma's investors?
Luminoma's investors include Angel HQ, Bridgewest Ventures, Pacific Channel.
Where is Luminoma headquartered?
Luminoma is headquartered in Auckland, NZ.